Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:42 pm Sale | 2026-06-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | RA CAPITAL MANAGEMENT L.P. | 8,392,730 7.800% | -2,035,707 (-19.52%) | Filing History |
| 2026-08-14 4:22 pm Purchase | 2026-06-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | Paradigm BioCapital Advisors LP | 10,215,455 9.500% | 3,674,245 (+56.17%) | Filing History |
| 2026-08-14 4:00 pm Sale | 2026-06-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | Baker Bros. Advisors LP | 3,701,719 3.400% | -3,604,221 (-49.33%) | Filing History |
| 2026-08-06 10:20 am Purchase | 2026-06-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | FMR LLC | 5,489,135 5.100% | 4,835,928 (+740.34%) | Filing History |
| 2026-05-15 11:42 am Purchase | 2026-03-31 | 13G | EDGEWISE THERAPEUTICS INC EWTX | JANUS HENDERSON GROUP Ltd. JHG | 5,915,556 5.500% | 936,225 (+18.80%) | Filing History |
| 2026-04-27 4:49 pm Sale | 2026-04-23 | 13D | EDGEWISE THERAPEUTICS INC EWTX | Novo Holdings A/S | 5,350,000 4.900% | -199,900 (-3.60%) | Filing History |
| 2026-02-17 4:02 pm Purchase | 2025-12-31 | 13G | EDGEWISE THERAPEUTICS INC EWTX | Paradigm BioCapital Advisors LP | 6,541,210 6.200% | 1,802,281 (+38.03%) | Filing History |
| 2025-11-14 4:15 pm Purchase | 2025-09-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | RA CAPITAL MANAGEMENT L.P. | 10,428,437 9.900% | 1,519,346 (+17.05%) | Filing History |
| 2025-11-14 10:24 am Sale | 2025-09-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | JANUS HENDERSON GROUP Ltd. JHG | 4,979,331 4.700% | -524,018 (-9.52%) | Filing History |
| 2025-08-14 4:28 pm Purchase | 2025-06-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | Baker Bros. Advisors LP | 7,305,940 6.900% | 1,465,881 (+25.10%) | Filing History |
| 2025-08-14 4:25 pm Sale | 2025-06-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | Perceptive Advisors LLC | 4,639,949 4.400% | -1,755,597 (-27.45%) | Filing History |
| 2025-08-14 11:44 am Purchase | 2025-06-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | JANUS HENDERSON GROUP Ltd. JHG | 5,503,349 5.200% | 221,195 (+4.19%) | Filing History |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | BlackRock, Inc. BLK | 5,824,866 5.500% | -568,701 (-8.89%) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | EDGEWISE THERAPEUTICS INC EWTX | Perceptive Advisors LLC | 6,395,546 6.100% | 1,231,059 (+23.84%) | Filing History |
| 2025-05-14 12:29 pm Purchase | 2025-03-31 | 13G | EDGEWISE THERAPEUTICS INC EWTX | JANUS HENDERSON GROUP Ltd. JHG | 5,282,154 5.600% | 298,214 (+5.98%) | Filing History |
| 2025-05-12 7:13 pm Purchase | 2025-05-09 | 13D | EDGEWISE THERAPEUTICS INC EWTX | ORBIMED ADVISORS LLC | 15,252,867 14.500% | 496,771 (+3.37%) | Filing History |
| 2025-02-21 5:57 pm Purchase | 2025-02-13 | 13G | EDGEWISE THERAPEUTICS INC EWTX | Perceptive Advisors LLC | 5,164,487 5.500% | 5,164,487 (New Position) | Filing History |
| 2025-02-14 11:24 am Purchase | 2024-12-31 | 13G | EDGEWISE THERAPEUTICS INC EWTX | JANUS HENDERSON GROUP Ltd. JHG | 4,983,940 5.300% | 4,983,940 (New Position) | Filing History |
| 2025-02-03 4:36 pm Purchase | 2025-01-27 | 13G | EDGEWISE THERAPEUTICS INC EWTX | Paradigm BioCapital Advisors LP | 4,738,929 5.000% | 4,738,929 (New Position) | Filing History |
| 2024-11-14 6:22 pm Sale | 2024-09-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | EcoR1 Capital, LLC | 1,250,385 1.300% | -2,242,809 (-64.21%) | Filing History |